Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion type Assertion NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_head.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion description "[In this study six patients with hormone-refractory prostate cancer were monitored for their ability to mount PSA-specific cellular responses after receiving a pVAX/PSA DNA vaccine (patients 1-3, 100 microg; patients 7-9, 900 microg) with recombinant GM-CSF and IL-2 as adjuvants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion evidence source_evidence_literature NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion SIO_000772 16000958 NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion wasDerivedFrom befree-20140225 NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.
- NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_assertion wasGeneratedBy ECO_0000203 NP694564.RAP9lfbepG05rLEjFXARcahEHdFs7gwI6CTCCiHQKTCQc130_provenance.